Life or death by NFκB, Losartan promotes survival in dy2J /dy2J mouse of MDC1A

M. Elbaz, N. Yanay, S. Laban, M. Rabie, S. Mitrani-Rosenbaum, Y. Nevo

Research output: Contribution to journalArticlepeer-review

Abstract

Inflammation and fibrosis are well-defined mechanisms involved in the pathogenesis of the incurable Laminin α2-deficient congenital muscular dystrophy (MDC1A), while apoptosis mechanism is barely discussed. Our previous study showed treatment with Losartan, an angiotensin II type I receptor antagonist, improved muscle strength and reduced fibrosis through transforming growth factor beta (TGF-β) and mitogen-activated protein kinases (MAPK) signaling inhibition in the dy2J /dy2J mouse model of MDC1A. Here we show for the first time that Losartan treatment up-regulates and shifts the nuclear factor kappa B (NFκB) signaling pathway to favor survival versus apoptosis/damage in this animal model. Losartan treatment was associated with significantly increased serum tumor necrosis factor alpha (TNF-α) level, p65 nuclei accumulation, and decreased muscle IκB-β protein level, indicating NFκB activation. Moreover, NFκB anti-apoptotic target genes TNF receptor-associated factor 1 (TRAF1), TNF receptor-associated factor 2 (TRAF2), cellular inhibitor of apoptosis (cIAP2), and Ferritin heavy chain (FTH1) were increased following Losartan treatment. Losartan induced protein expression toward a pro-survival profile as BCL-2 expression levels were increased and Caspase-3 expression levels were decreased. Muscle apoptosis reduction was further confirmed using terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) assay. Thus, along with TGF-β and MAPK signaling, NFκB serves as an important regulatory pathway which following Losartan treatment promotes survival in the dy2J /dy2J mouse model of MDC1A.

Original languageEnglish
Article numbere1690
JournalCell Death and Disease
Volume6
Issue number3
DOIs
StatePublished - 2015
Externally publishedYes

Fingerprint

Dive into the research topics of 'Life or death by NFκB, Losartan promotes survival in dy2J /dy2J mouse of MDC1A'. Together they form a unique fingerprint.

Cite this